Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 522

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 522
---
 ​ | ​ | ​ | ​    | ​ |  5,048 | ​ | ​ |
| Cash, beginning of the year                                                  | ​ | ​ | ​                       | ​ |  5,048 | ​ | ​ | ​ | ​    | ​ |      — | ​ | ​ |
| Cash, end of the year                                                        | ​ | ​ | ​                       | $ |    434 | ​ | ​ | ​ | ​    | $ |  5,048 | ​ | ​ |
| Supplemental disclosure of cash flow information                             | ​ | ​ | ​                       | ​ |      ​ | ​ | ​ | ​ | ​    | ​ |      ​ | ​ | ​ |
| Cash paid for interest                                                       | ​ | ​ | ​                       | $ |      — | ​ | ​ | ​ | ​    | $ |    503 | ​ | ​ |
| Cash paid for income taxes                                                   | ​ | ​ | ​                       | $ |      — | ​ | ​ | ​ | ​    | $ |      — | ​ | ​ |
| Supplemental disclosure of non-cash financing and investing activities:      | ​ | ​ | ​                       | ​ |      ​ | ​ | ​ | ​ | ​    | ​ |      ​ | ​ | ​ |
| Cancellation of member units related to Metavagen license termination        | ​ | ​ | ​                       | $ |    239 | ​ | ​ | ​ | ​    | ​ |      ​ | ​ | ​ |
| Issuance of Class A member units in exchange for CD-47 License Agreement     | ​ | ​ | ​                       | $ |    786 | ​ | ​ | ​ | ​    | $ |      — | ​ | ​ |
| Issuance of Class A member units in exchange for Metavagen License Agreement | ​ | ​ | ​                       | ​ |      ​ | ​ | ​ | ​ | ​    | $ |    400 | ​ | ​ |

The accompanying notes are an integral part of these financial statements. F-74

TABLE OF CONTENTS

#### LIMINATUS PHARMA, LLC

### NOTES TO FINANCIAL STATEMENTSDECEMBER 31, 2023 AND 2022

### Note 1. Organization and Description of Business Operations
Liminatus Pharma, LLC (“Liminatus” or the “Company”) was formed by issuing member units to Consonatus, Inc. (the “Initial Member